Research looks at therapeutic inertia related to injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in people with type 2 diabetes
3rd February 2023
Multiple examples of therapeutic inertia in type 2 diabetes have been identified in a new research study. A team of academics have detected that the first prescription at HbA1c levels were ...
